Trademark: 87121316
Status Date
Monday, February 4, 2019
Filing Date
Friday, July 29, 2016
Published for Opposition
Tuesday, November 7, 2017
Abandoned Date
Monday, February 4, 2019
5 (Based on 44(e)) (Based on Intent to Use) pharmaceutical and veterinary preparations and substances allowing for controlled absorption and/or controlled release of an active ingredient following administration to human and non-human animals for the treatment of cardiovascular disorders, central nervous system disorders, acute and chronic pain, epilepsy, insomnia, learning disorders, infectious diseases, gastrointestinal diseases, diabetes, impotence, obesity, skin disorders, host-graft rejections, arthritis and autoimmune disorders; (Based on Intent to Use) Pharmaceutical and veterinary preparations and substances for the treatment of cardiovascular disorders, central nervous system disorders, acute and chronic pain, epilepsy, insomnia, learning disorders, infectious diseases, gastrointestinal diseases, diabetes, impotence, obesity, skin disorders, host-graft rejections, arthritis and autoimmune disorders
42 (Based on 44(e)) (Based on Intent to Use) Scientific and biological research relating to the research and development of pharmaceutical and veterinary preparations and substances allowing for controlled absorption and/or controlled release of an active ingredient following administration to human and non-human animals and based on liquid emulsion drug delivery systems; medical research relating to the diagnosis and treatment of disease involving the use of pharmaceutical and veterinary preparations and substances allowing for controlled absorption and/or controlled release of an active ingredient following administration to human and non-human animals and based on liquid emulsion drug delivery systems; (Based on Intent to Use) Scientific and biological research relating to the research and development of pharmaceutical and veterinary preparations and substances; medical research relating to the diagnosis and treatment of disease; medical research on the efficacy of pharmaceutical and veterinary preparations and substances; medical and scientific research, namely, conducting clinical trials involving pharmaceutical and veterinary preparations and substances
Feb 4, 2019
Abandonment Notice E-Mailed - No Use Statement Filed
Feb 4, 2019
Abandonment - No Use Statement Filed
Jun 9, 2018
Notice Of Approval Of Extension Request E-Mailed
Jun 7, 2018
Extension 1 Granted
Jun 7, 2018
Extension 1 Filed
Jun 7, 2018
Teas Extension Received
Jan 2, 2018
Noa E-Mailed - Sou Required From Applicant
Nov 7, 2017
Official Gazette Publication Confirmation E-Mailed
Nov 7, 2017
Published For Opposition
Oct 18, 2017
Notification Of Notice Of Publication E-Mailed
Oct 3, 2017
Electronic Record Review Complete
Sep 29, 2017
On Hold - Electronic Record Review Required
Sep 22, 2017
Electronic Record Review Complete
Sep 15, 2017
On Hold - Electronic Record Review Required
Sep 13, 2017
Approved For Pub - Principal Register
Sep 11, 2017
Examiner's Amendment Entered
Sep 11, 2017
Notification Of Examiners Amendment E-Mailed
Sep 11, 2017
Examiners Amendment E-Mailed
Sep 11, 2017
Examiners Amendment -Written
Aug 10, 2017
Teas/Email Correspondence Entered
Aug 10, 2017
Correspondence Received In Law Office
Aug 10, 2017
Teas Response To Office Action Received
May 8, 2017
Notification Of Non-Final Action E-Mailed
May 8, 2017
Non-Final Action E-Mailed
May 8, 2017
Non-Final Action Written
Apr 13, 2017
Teas/Email Correspondence Entered
Apr 13, 2017
Correspondence Received In Law Office
Apr 10, 2017
Assigned To Lie
Mar 27, 2017
Teas Response To Office Action Received
Nov 15, 2016
Notification Of Non-Final Action E-Mailed
Nov 15, 2016
Non-Final Action E-Mailed
Nov 15, 2016
Non-Final Action Written
Nov 9, 2016
Assigned To Examiner
Aug 3, 2016
New Application Office Supplied Data Entered In Tram
Aug 2, 2016
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
